{"id":"NCT00606281","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2008-02-01","resultsPosted":"2014-02-12","lastUpdate":"2014-02-12"},"enrollment":258,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar I Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["OPC-14597"]},{"type":"DRUG","name":"placebo","otherNames":["OPC-14597"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this trial is to evaluate the clinical efficacy and safety of aripiprazole in comparison to placebo in patients with Bipolar I Disorder experiencing a manic or mixed episode.","primaryOutcome":{"measure":"Young Mania Rating Scale (YMRS)","timeFrame":"Day1, Day21","effectByArm":[{"arm":"Aripiprazole","deltaMin":-11.3,"sd":1.31},{"arm":"Placebo","deltaMin":-5.3,"sd":1.29}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":12,"countries":["China","Japan","South Korea","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":123},"commonTop":["Akathisia","Insomnia","Vomiting","Tremor","Constipation"]}}